Dudediligence.

Eikon Therapeutics, Inc

EIKNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Regulation FD disclosureAug 13 →Insiders23 insiders bought $52.2M in 10 open-market buys. No sales.→HoldersFMR 9.2%BlackRock 7.9%Foresite Capital Management IV 3.6%→Financing →PeersClosest companies: IMRX, GLUE, IDYA→

From the filings

Figures

Cash and equivalents
$142.6Mat the last balance sheet
Shares outstanding
54.1M shareson issue
Every year and quarter →